![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07D 401/12 | |
A61K 31/519 | |||
A61P 35/00 |
(11) | Number of the document | 2638030 |
(13) | Kind of document | T |
(96) | European patent application number | 11791110.7 |
Date of filing the European patent application | 2011-11-09 | |
(97) | Date of publication of the European application | 2013-09-18 |
(45) | Date of publication and mention of the grant of the patent | 2020-04-15 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2011/059890 |
Date | 2011-11-09 |
(87) | Number | WO 2012/064805 |
Date | 2012-05-18 |
(30) | Number | Date | Country code |
412064 P | 2010-11-10 | US |
(72) |
CALIENNI, John Vincent, US
CHEN, Guang-Pei, US
GONG, Baoqing, US
KAPA, Prasad Koteswara, US
SAXENA, Vishal, US
|
(73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
Astex Therapeutics Limited, 436 Cambridge Science Park Milton Park Cambridge, Cambridgeshire CB4 0QA, GB |
(54) | SUCCINATE SALT OF 7-CYCLOPENTYL-2 -(5-PIPERAZIN-1-YL-PYRIDIN-2-YLAMINO)-7H-PYRROLO[2,3-D]PYRIMIDINE-6-CARBOXYLIC ACID DIMETHYLAMIDE AND PROCESSES OF MAKING THEREOF |
SUCCINATE SALT OF 7-CYCLOPENTYL-2 -(5-PIPERAZIN-1-YL-PYRIDIN-2-YLAMINO)-7H-PYRROLO[2,3-D]PYRIMIDINE-6-CARBOXYLIC ACID DIMETHYLAMIDE AND PROCESSES OF MAKING THEREOF |